Sampling or node dissection for intraoperative staging of lung cancer: a multicentric cross-sectional study

European Journal of Cardio-thoracic Surgery

Volumn 30, Issue 1, 2006, Pages 164-167

  Massard, Gilbert ^a   Ducrocq, Xavier ^a   Kochetkova, Evgenia A ^a   Porhanov, Vladimir A ^b   Riquet, Marc ^c  

^a HÔPITAL CIVIL   (France)

^b Cardiothoracic Center   (Russian Federation)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Lung cancer; Lymph node dissection; Surgery

Indexed keywords

ADENOSQUAMOUS CARCINOMA; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTRAOPERATIVE PERIOD; LARGE CELL CARCINOMA; LOBECTOMY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG CARCINOMA; LUNG RESECTION; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; PREDICTION; PRIORITY JOURNAL; SAMPLING; SQUAMOUS CELL CARCINOMA; SURGEON; SURGICAL PATIENT;

CARCINOMA, NON-SMALL-CELL LUNG; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PNEUMONECTOMY;

EID: 33744943323     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2006.04.010     Document Type: Article

References (11)

1. Gdeedo A., van Schil P., Corthouts B., van Mieghem F., van Meerbeeck J., and van Marck E. Comparison of imaging TNM [(i)TNM] and pathological TNM [pTNM] in staging of bronchogenic carcinoma. Eur J Cardiothorac Surg 12 (1997) 224-227
2. Cerfolio R.J., Ojha B., Bryant A.S., Bass C.S., Bartalucci A.A., and Mountz J.M. The role of FDG-PET scan in staging patients with nonsmall cell carcinoma. Ann Thorac Surg 76 (2003) 861-866
3. Nomori H., Watanabe K., Ohtsuka T., Naruke T., Suemasu K., and Uno K. The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer. J Thorac Cardiovasc Surg 127 (2004) 1087-1092
4. Riquet M., Manac'h D., Le Pimpec Barthes F., Dujon A., Debrosse D., and Debesse B. Prognostic value of T and N in non-small cell lung cancer three centimeters or less in diameter. Eur J Cardiothorac Surg 11 (1997) 440-444
5. Gajra A., Newman N., Gamble P., Kohman L.J., and Graziano S.L. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small cell lung cancer. J Clin Oncol 21 (2003) 1029-1033
6. Doddoli C., Aragon A., Barlesi F., Chetaille B., Robitail S., Giudicelli R., Fuentes P., and Thomas P. Does the extent of lymph node dissection influence outcome in patients with stage I non-small cell lung cancer?. Eur J Cardiothorac Surg 27 (2005) 680-685
7. Lardinois D., Suter H., Hakki H., Rousson V., Betticher D., and Ris H.B. Morbidity, survival and site of recurrence after mediastinal lymph node dissection versus systematic sampling after complete resection for non-small cell lung cancer. Ann Thorac Surg 80 (2005) 268-275
8. Keller S., Adak S., Wagner H., Johnson D.H., and for the Eastern Cooperative Oncology group. Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Ann Thorac Surg 70 (2000) 358-366
9. Wu Y., Huang Z., Wang S., Yang X., and Ou W. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer 36 (2002) 1-6
10. The International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin basee adjuvant chemotherapy in patients with completely resected non-small cell lung cancer. N Engl J Med 350 (2004) 351-360
11. Depierre A., Milleron B., Moro-Sibilot D., Chevret S., Quoix E., Lebeau B., Braun D., Breton J.L., Lemarie E., Gouva S., Paillot N., Brechot J.M., Janicot H., Lebas F.X., Terrioux P., Clavier J., Foucher P., Monchatre M., Coetmeur D., Level M.C., Leclerc P., Blanchon F., Rodier J.M., Thiberville L., Villeneuve A., Westeel V., Chastang C., and French Thoracic Cooperative Group. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II and IIIa non-small cell lung cancer. J Clin Oncol 20 (2002) 247-253